COGENT BIOSCIENCES INC's ticker is COGT and the CUSIP is 19240Q201. A total of 135 filers reported holding COGENT BIOSCIENCES INC in Q3 2022. The put-call ratio across all filers is 0.24 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $7,531,749 | -17.7% | 777,487 | +0.6% | 0.05% | -19.7% |
| Q2 2023 | $9,146,246 | -1.7% | 772,487 | -17.6% | 0.07% | +1.5% |
| Q1 2023 | $9,307,211 | -19.3% | 937,141 | -6.0% | 0.06% | -16.7% |
| Q4 2022 | $11,526,410 | -32.9% | 997,141 | -13.4% | 0.08% | -35.5% |
| Q3 2022 | $17,181,000 | +52.3% | 1,151,502 | -7.9% | 0.12% | +30.1% |
| Q2 2022 | $11,283,000 | -14.1% | 1,250,889 | -28.6% | 0.09% | +4.5% |
| Q1 2022 | $13,129,000 | -18.0% | 1,752,980 | -6.0% | 0.09% | -12.7% |
| Q4 2021 | $16,008,000 | -1.2% | 1,865,772 | -3.2% | 0.10% | -7.3% |
| Q3 2021 | $16,207,000 | +4.6% | 1,927,249 | +0.9% | 0.11% | +3.8% |
| Q2 2021 | $15,496,000 | +202.5% | 1,910,720 | +302.4% | 0.11% | +146.5% |
| Q1 2021 | $5,122,000 | -3.9% | 474,809 | +0.0% | 0.04% | +2.4% |
| Q4 2020 | $5,331,000 | – | 474,730 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TCG Crossover Management, LLC | 3,481,042 | $31,399,000 | 13.34% |
| Atlas Venture Associates IX, LLC | 466,832 | $4,211,000 | 9.57% |
| COMMODORE CAPITAL LP | 4,944,708 | $44,601,000 | 9.43% |
| VR Adviser, LLC | 4,038,117 | $36,424,000 | 7.17% |
| Ally Bridge Group (NY) LLC | 857,352 | $7,733,000 | 7.05% |
| Fairmount Funds Management LLC | 2,758,975 | $24,886,000 | 5.70% |
| Ghost Tree Capital, LLC | 900,000 | $8,118,000 | 4.23% |
| New Leaf Venture Partners, L.L.C. | 501,530 | $4,524,000 | 2.93% |
| 5AM Venture Management, LLC | 1,129,200 | $10,185,000 | 2.52% |
| Kynam Capital Management, LP | 1,000,000 | $9,020,000 | 2.30% |